CASP9 and glioblastoma: Our results showed that an elevation in level of p53 after combination therapy induced the mitochondrial pathway of apoptosis for activation of caspase-9, which in turn activated caspase-3 for completion of apoptosis in glioblastoma cells both in culture and xenograft models.